Early Predictive Biochemical, Electrocardiographic and Echocardiographic Markers for Cardiac Damage in Patients with Pulmonic Silicosis

Abstract

The aim of this study was to identify correlations between electrocardiographic and echocardiographic changes in patients with silicosis prior to the occurrence of chronic pulmonary heart disease. We conducted a prospective, descriptive, analytical study, in which we included a group of 67 patients consecutively admitted to the Health Promotion and Occupational Medicine Clinic between December 2016 and January 2018, aged 47 to 78 years.There was a biochemical and electrocardiographic evaluation for each patient as well as a right ventricle echocardiographic evaluation (diameters, volumes, function). A control group, including 25 patients with benign minor diseases that required a cardiologist consultation, was also used. From the electrocardiographic point of view, slight changes were observed regarding the waves of electrical activity of the right ventricle. Taking into account the degree of ventilatory dysfunction (depending on FEV1), changes in right heart echocardiographic parameters were identified. Thus, in what the most important right ventricular parameters, including the tricuspid annular plane systolic excursion (TAPSE) or the RV index of myocardial performance (RVMPI) were concerned, values at the upper limit of normality were recorded in most patients with moderate and severe ventilatory dysfunction. Values of echocardiographic parameters of the right heart at the upper limit of normality, correlated with the degree of ventilatory dysfunction, are early markers for cardiovascular damage in patients with pulmonary silicosis prior to the occurrence of chronic pulmonary heart disease also known ascor pulmonale.

Immunohistochemical analisys in Breast Carcinoma Treated with Conservative Surgery

“…The results were comparable to those obtained in similar studies that concluded that almost 50% of invasive mammary carcinomas have both receptors positive whilst 25% are lacking in them [8][9][10][11][12]. The ER+/PR-phenotype represents a distinct group because it usually is accompanied by high clinical and biological aggressiveness and have the least satisfactory response to hormone therapy in comparison to other phenotypes [13][14][15][16].…”

Assessing the Risk Factors of Patients with Non-ST-Segment Elevation Myocardial Infarction

“…Our study included 305 patients with NSTEMI whose mean age was 70.62 ± 11.05 years CI 95% (69.28 -71.77) confirming the presence of non-ST-segment elevation myocardial infarction at older age [7][8][9][10][11] being more than 5 years old for women (73.36 ± 10.05 years) than for males (68.3 ± 11.32 years).…”

Prognostic Value of Ejection Fraction in Patients Admitted with Non-ST-Segment Elevatin Myocardial Infarction

“…Echocardiography represents the imaging method of choice for assessing ventricular function in patients with clinical cardiac disease [1][2][3][4][5][6]. The multiple advantages are: echocardiography in emergency conditions, at hemodynamically unstable patients, it has good accuracy and is noninvasive and provides decisive information for diagnosis, risk stratification, therapeutic decision and follow-up of treatment effects.…”